MONTELUKAST SODIUM 10mg. IP + LEVOCETIRIZINE 5mg. IP

An antiallergic medication that provides symptomatic treatment of allergic rhinitis, chronic idiopathic urticaria, and obstructive airway diseases. Has a dual mechanism of action and acts both as a bronchodilator and anti-inflammatory agent. (Mohini Sachin Mahatme, 2016) A more effective approach than monotherapy in the treatment of persistent allergic rhinitis. (S M Adsule, 2010) Significantly alleviates nasal symptoms associated with persistent allergic rhinitis. (Maciej Ciebiada, 2011) A potential therapeutic agent that effectively treats cases of recalcitrant chronic urticaria. (Tushar Kanti Sarkar, 2017) An effective antihistamine for treating influenza, common cold, and acute inflammation. (Bhattacharyya, 2020) A beneficial medication that eases symptoms of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. (Devada Singh-Franco, 2009) An effective and safe therapeutic option in treating perennial allergic rhinitis patients with asthma compared with montelukast alone. (Mi-Kyeong Kim, 2018) Ameliorates the naso-ocular symptoms and health-related quality of life in seasonal allergic rhinitis. (Nathan Segall, 2010) An effective prophylactic agent for asthma and relieves symptoms of seasonal allergies.